Foster common approaches between People’s Republic of China and the European Union on Personalised Medicine research, development, innovation and policies
News
ERA PerMed joint call 2021 – Submit your PM-focused transnational project now
ERA PerMed, ERA-NET programme monitored by ICPerMed consortium, fosters research and innovation activities that build close linkages between [...]
SAVE THE DATE – IC2PerMed workshop on EU-China policies and programmes for Personalised Medicine – 23/11/2020 – 9:30 CET
IC2PerMed project will hold its first e-workshop “Policies and programs in the field of Personalized medicine: first results [...]
ICPerMed Recognition 2020 & ERA PerMed Newsletter #4
IC2PerMed project core aim is to support ICPerMed consortium developments. Thus, please find below two interesting news from [...]
IC2PerMed at a glance
Supporting International collaboration for the development of Personalised Medicine
The International Consortium for Personalised Medicine (ICPerMed), umbrella initiative of IC2PerMed, aims at initiating and supporting communication and exchange on Personalised Medicine (PM) for aligning national agendas on research and funding activities. It brings together representatives of funding agencies and authorities from 29 countries and expands for increasing PM developments’ synergies at international level.
IC2PerMed project’s core objective is to build upon collaborative developments of Chinese and European experts on PM for elaborating a common strategy, enabling Chinese institutions to join the ICPerMed consortium. The 3 Expert Working Groups will set the path for a common approach of PM research, innovation, development and implementation over the project duration.
